ESMO 2024
Find the latest updates for oncology nurses from the European Society of Medical Oncology (ESMO) Congress 2024, which took place from September 13-17, in Barcelona, Spain.
The multi-site, retrospective study assessed patients with advanced urothelial carcinoma and neuropathy or diabetes mellitus.
Learn how a team developed a predictive model for breast cancer using cfDNA low-pass whole genome sequencing.
Patients who received the vaccine within 100 days of starting an immune checkpoint inhibitor showed improved survival.
The study analyzed quality-adjusted time without symptoms of disease progression or toxicity of treatment, known as Q-TWiST.
Learn what a team found when they implemented a pre-appointment electronic PRO measure for patients with prostate cancer.
The personalized, stratified follow-up pathway is led by advanced nurse practitioners and general practitioners.
The study investigators say the 5-year survival rate "dramatically exceeds historical standards."
A team used an interpretive description approach to evaluate the self-management support intervention.
A randomized study is evaluating a nurse-led educational intervention on physical activity for patients with breast cancer.
Advertisement
Advertisement
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.